A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
Phase 2, randomized, double-blind, multiple arm, controlled study to evaluate safety &
efficacy of various doses of STP705 in reducing post Keloidectomy keloid recurrence.